Erratum to: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay

Wendy E. Heywood, Daniela Galimberti, Emily Bliss, Ernestas Sirka, Ross W. Paterson, Nadia K. Magdalinou, Miryam Carecchio, Emma Reid, Amanda Heslegrave, Chiara Fenoglio, Elio Scarpini, Jonathan M. Schott, Nick C. Fox, John Hardy, Kailash P. Bhatia, Simon Heales, Neil J. Sebire, Henrik Zetterberg, Kevin Mills

Research output: Contribution to journalArticle

Original languageEnglish
JournalMolecular Neurodegeneration
DOIs
Publication statusAccepted/In press - Feb 23 2016

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Clinical Neurology
  • Molecular Biology

Cite this

Heywood, W. E., Galimberti, D., Bliss, E., Sirka, E., Paterson, R. W., Magdalinou, N. K., Carecchio, M., Reid, E., Heslegrave, A., Fenoglio, C., Scarpini, E., Schott, J. M., Fox, N. C., Hardy, J., Bhatia, K. P., Heales, S., Sebire, N. J., Zetterberg, H., & Mills, K. (Accepted/In press). Erratum to: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay. Molecular Neurodegeneration. https://doi.org/10.1186/s13024-016-0086-3